Latest Articles

Publication Date
Not Only Women Menstruate: Mice Now Have Periods—and It Could Redefine Reproductive Health - MSN

Not Only Women Menstruate: Mice Now Have Periods—and It Could Redefine Reproductive Health MSN

Published: Oct. 24, 2025, 5:25 p.m.
Lowe's has a BOGO deal that gets you a free Bosch power tool - Mashable

Lowe's has a BOGO deal that gets you a free Bosch power tool Mashable

Published: Oct. 24, 2025, 5:14 p.m.
'It took me three attempts to get PIP. Now I've found a work coach that actually understands disabled people' - AOL.co.uk

'It took me three attempts to get PIP. Now I've found a work coach that actually understands disabled people' AOL.co.uk

Published: Oct. 24, 2025, 4:27 p.m.
Renewed Women's Health strategy essential for equity and improved care for women - NHS Confederation

Renewed Women's Health strategy essential for equity and improved care for women NHS Confederation

Published: Oct. 24, 2025, 4:04 p.m.
Quanta Therapeutics Presents Positive Phase 1 Data for QTX3034, an Oral G12D-Preferring Multi-KRAS Inhibitor, in Patients with Advanced Solid Tumors - The Manila Times

Quanta Therapeutics Presents Positive Phase 1 Data for QTX3034, an Oral G12D-Preferring Multi-KRAS Inhibitor, in Patients with Advanced Solid Tumors The Manila Times

Published: Oct. 24, 2025, 3:57 p.m.
Woodbridge Trader Joes On Rt. 1 Announces Opening Date - Patch

Woodbridge Trader Joes On Rt. 1 Announces Opening Date Patch

Published: Oct. 24, 2025, 2:40 p.m.
Women’s health is not niche: It’s the future of healthcare - FemTech World

Women’s health is not niche: It’s the future of healthcare FemTech World

Published: Oct. 24, 2025, 1:03 p.m.
Correction: Endometrial cancer (EC) derived G3BP1 overexpression and mutant promote EC tumorigenesis and metastasis via SPOP/ERα axis - Cell Communication and Signaling

Correction: Endometrial cancer (EC) derived G3BP1 overexpression and mutant promote EC tumorigenesis and metastasis via SPOP/ERα axis Cell Communication and Signaling

Published: Oct. 24, 2025, 12:50 p.m.
Low-Dose Dienogest: 48 Weeks of Endometriosis Relief - Bioengineer.org

Low-Dose Dienogest: 48 Weeks of Endometriosis Relief Bioengineer.org

Published: Oct. 24, 2025, 11:21 a.m.
Treatment paradigm for recurrent endometriosis shifts from surgery to medication - koreabiomed.com

Treatment paradigm for recurrent endometriosis shifts from surgery to medication koreabiomed.com

Published: Oct. 24, 2025, 8:01 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!